MEDEFY HEALTH INC. – Trademark Portfolio
Entity Type: 03
MEDEFY HEALTH INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include MEDEFY, NAVIGATEWAY, and SUPERHUMAN BENEFITS NAVIGATION. The owner is based in TULSA, OK.
15 E. 5TH STREET, 27TH FLOOR
TULSA, OK 74103
Showing of trademarks Trademarks
Trademark Classifications
MEDEFY HEALTH INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does MEDEFY HEALTH INC. have?
MEDEFY HEALTH INC. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does MEDEFY HEALTH INC. file in?
MEDEFY HEALTH INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are MEDEFY HEALTH INC.'s most well-known trademarks?
MEDEFY HEALTH INC.'s registered trademark portfolio includes well-known marks such as MEDEFY, NAVIGATEWAY, and SUPERHUMAN BENEFITS NAVIGATION. These are among 5 currently registered trademarks in the portfolio.
What is MEDEFY HEALTH INC.'s trademark registration success rate?
MEDEFY HEALTH INC. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.